These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34534223)

  • 21. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleeping sickness in Zaire: a nested polymerase chain reaction improves the identification of Trypanosoma (Trypanozoon) brucei gambiense by specific kinetoplast DNA probes.
    Schares G; Mehlitz D
    Trop Med Int Health; 1996 Feb; 1(1):59-70. PubMed ID: 8673824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent lack of a domestic animal reservoir in Gambiense sleeping sickness in northwest Uganda.
    Balyeidhusa AS; Kironde FA; Enyaru JC
    Vet Parasitol; 2012 Jun; 187(1-2):157-67. PubMed ID: 22245071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo.
    Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V
    Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
    Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
    Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance evaluation of a prototype rapid diagnostic test for combined detection of gambiense human African trypanosomiasis and malaria.
    Lumbala C; Matovu E; Sendagire H; Kazibwe AJN; Likwela JL; Muhindo Mavoko H; Kayembe S; Lutumba P; Biéler S; Van Geertruyden JP; Ndung'u JM
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008168. PubMed ID: 32251426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and prevalence of human African trypanosomiasis in individuals living in remote areas of the republic of Congo.
    Elenga VA; Lissom A; Elion DOA; Vouvoungui JC; Djontu JC; Boumpoutou RK; Ahombo G; Ntoumi F
    BMC Public Health; 2022 Dec; 22(1):2322. PubMed ID: 36510162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens.
    Lumbala C; Biéler S; Kayembe S; Makabuza J; Ongarello S; Ndung'u JM
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006386. PubMed ID: 29590116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage determination in sleeping sickness: comparison of two cell counting and two parasite detection techniques.
    Mumba Ngoyi D; Menten J; Pyana PP; Büscher P; Lejon V
    Trop Med Int Health; 2013 Jun; 18(6):778-82. PubMed ID: 23506188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of loopamp Trypanosoma brucei detection kit for diagnosis of human African trypanosomiasis in clinical samples.
    Mitashi P; Hasker E; Ngoyi DM; Pyana PP; Lejon V; Van der Veken W; Lutumba P; Büscher P; Boelaert M; Deborggraeve S
    PLoS Negl Trop Dis; 2013; 7(10):e2504. PubMed ID: 24147176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Trypanosoma brucei gambiense sleeping sickness using an antigen detection enzyme-linked immunosorbent assay.
    Nantulya VM; Doua F; Molisho S
    Trans R Soc Trop Med Hyg; 1992; 86(1):42-5. PubMed ID: 1566302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study.
    Bisser S; Lumbala C; Nguertoum E; Kande V; Flevaud L; Vatunga G; Boelaert M; Büscher P; Josenando T; Bessell PR; Biéler S; Ndung'u JM
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004608. PubMed ID: 27058033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness.
    Lejon V; Robays J; N'Siesi FX; Mumba D; Hoogstoel A; Bisser S; Reiber H; Boelaert M; Büscher P
    Clin Vaccine Immunol; 2007 Jun; 14(6):732-7. PubMed ID: 17428948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human African trypanosomiasis transmission, Kinshasa, Democratic Republic of Congo.
    Simo G; Mansinsa Diabakana P; Kande Betu Ku Mesu V; Manzambi EZ; Ollivier G; Asonganyi T; Cuny G; Grébaut P
    Emerg Infect Dis; 2006 Dec; 12(12):1968-70. PubMed ID: 17326955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients.
    Kaboré J; Koffi M; Bucheton B; MacLeod A; Duffy C; Ilboudo H; Camara M; De Meeûs T; Belem AM; Jamonneau V
    Infect Genet Evol; 2011 Aug; 11(6):1250-5. PubMed ID: 21530681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo.
    Boelaert M; Mukendi D; Bottieau E; Kalo Lilo JR; Verdonck K; Minikulu L; Barbé B; Gillet P; Yansouni CP; Chappuis F; Lutumba P
    EBioMedicine; 2018 Jan; 27():11-17. PubMed ID: 29246478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
    Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
    Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.